BioSens8
1 known investors
BioSens8 develops a platform that identifies microbes to engineer biosensors for quantitative, real-time, and continuous monitoring. The company is expanding its biosensor technology beyond glucose monitoring.
Investors · 1
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase ISTTR | 2021 | $256K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.